Adcock Ingram Holdings | AIP - Cost Of Sales



Adcock Ingram Holdings reported ZAR3.18B in Cost of Sales for its fiscal semester ending in December of 2024.


Cost Of Sales Change Date
Adcock Ingram Holdings ZAR 3.18B 115.21M Dec/2024
Alaunos Therapeutics 0 18K Sep/2024
Aspen Pharmacare ZAR 11.51B 1.92B Dec/2024
Avita Medical AUD 2.28M 170K Dec/2024
Ionis Pharmaceuticals USD 4.15M 3.15M Jun/2025
IQVIA Holdings USD 2.97B 439M Jun/2025
Life Healthcare 8.67B 997M Sep/2024
Moderna USD 119M 29M Jun/2025
Netcare ZAR 6.67B 588M Sep/2024
Organon & Co USD 720M 48M Jun/2025
Revvity USD 327.73M 38.51M Jun/2025
Viatris USD 2.25B 229.7M Jun/2025
Xeris Pharmaceuticals USD 11.9M 2.42M Jun/2025